n particular one or more tumor associated antigens. [0005] Another aspect of the invention is a composition comprising a recombinant replication-defective virus encoding GM-CSF in combination with a vector expressing an antigen, alone or in combination with at least one immunostimulatory molecule. [0006] An additional aspect of the invention is a composition comprising a recombinant replication-de